Phase IV objectives may include the assessment of which type of parameters?

Phase IV objectives may include the assessment of which type of parameters?

• A. Pharmacodynamic markers
• B. Pharmacokinetic parameters
• C. Manufacturing yield
• D. Animal toxicity

Answer: (B)

Phase IV studies focus on long-term safety and real-world use after a drug is approved. In that setting, assessing pharmacokinetic parameters can be important to understand how the drug behaves in broader patient populations, including how factors like age, organ function, or concomitant medications affect absorption, distribution, metabolism, and excretion. This helps fine-tune dosing or labeling when the drug is used outside of controlled trials. Pharmacodynamic markers are typically explored earlier in development to establish dose-response relationships. Manufacturing yield relates to production processes rather than patient outcomes, and animal toxicity is a preclinical concern, not a post-marketing clinical objective.

Phase IV studies focus on long-term safety and real-world use after a drug is approved. In that setting, assessing pharmacokinetic parameters can be important to understand how the drug behaves in broader patient populations, including how factors like age, organ function, or concomitant medications affect absorption, distribution, metabolism, and excretion. This helps fine-tune dosing or labeling when the drug is used outside of controlled trials.

Pharmacodynamic markers are typically explored earlier in development to establish dose-response relationships. Manufacturing yield relates to production processes rather than patient outcomes, and animal toxicity is a preclinical concern, not a post-marketing clinical objective.